Sodium-Glucose Co-Transporter-2 Inhibitors (SGLT2i) are commonly used for patients with diabetes but are implicated in perioperative Diabetic Ketoacidosis (DKA), which may occur with normal or minimally elevated blood glucose (euglycaemic DKA).

Gliflozin Guide helps determine on the best management for patients taking SGLT2i medications in the perioperative period.

By using this app, you hereby consent to our disclaimer and agree to its terms.

Copyright 2020